The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Alimera Sciences, Inc. Common Stock 016259103 4,887 3,973,217 SH   OTR   0 3,973,217 0
Everyday Health, Inc. Common Stock 300415106 8,621 1,094,085 SH   OTR   0 1,094,085 0
Horizon Pharma plc Common Stock G4617B105 28,171 1,710,451 SH   OTR   0 1,710,451 0
Orexigen Therapeutics, Inc. Common Stock 686164104 564 1,312,575 SH   OTR   0 1,312,575 0